Browsing Tag
PureTech Health
5 posts
Why Seaport’s U.S. IPO filing matters now for neuropsychiatric drug development and biotech capital markets
Seaport Therapeutics has filed for a U.S. IPO. Read how its neuropsychiatry pipeline could test biotech investor appetite in 2026.
April 11, 2026
Digital medicine firm Akili Interactive to merge with Social Capital Suvretta
Akili Interactive, a US-based digital medicine company, has agreed to merge with Social Capital Suvretta Holdings Corp. I…
January 29, 2022
Microbiome company Vedanta Biosciences raises $68m in Series D
Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D…
July 21, 2021
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…
July 18, 2019
Vedanta Biosciences secures $27m to propel microbiome drug pipeline
US-based Vedanta Biosciences has raised $27 million in a Series C financing round to accelerate its pioneering work…
December 25, 2018